Simon Gilbody Selected Research

Simon Gilbody Research Topics

Disease

9	Mental Disorders (Mental Disorder) 01/2021 - 01/2007
9	Anxiety Disorders (Anxiety Disorder) 11/2019 - 01/2007
6	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 07/2002
6	Schizophrenia (Dementia Praecox) 05/2019 - 07/2002
5	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 01/2007
3	Major Depressive Disorder (Major Depressive Disorders) 01/2017 - 02/2012
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 11/2021 - 01/2021
2	Panic Disorder (Panic Attack) 01/2021 - 01/2021
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 01/2020
2	Treatment-Resistant Depressive Disorder 11/2018 - 02/2016
2	Depressive Disorder (Melancholia) 10/2010 - 01/2007
1	Autism Spectrum Disorder 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2021
1	Inflammation (Inflammations) 05/2021
1	Conversion Disorder (Astasia Abasia) 05/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Frailty 01/2020
1	Ambulatory Care Sensitive Conditions 12/2019
1	Alcohol-Related Disorders 05/2019
1	Autistic Disorder (Autism) 01/2019
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2017
1	Treatment-Resistant Schizophrenia 09/2016
1	Substance-Related Disorders (Drug Abuse) 01/2016
1	Tobacco Use Disorder (Nicotine Dependence) 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Chronic Disease (Chronic Diseases) 09/2015
1	Hip Fractures (Intertrochanteric Fractures) 06/2006
1	Fatigue 07/2002
1	Sialorrhea 07/2002
1	Dizziness (Lightheadedness) 07/2002

Drug/Important Bio-Agent (IBA)

8	Antidepressive Agents (Antidepressants)IBA 01/2022 - 02/2012
6	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 07/2002
5	Pharmaceutical PreparationsIBA 01/2020 - 09/2012
3	SmokeIBA 01/2021 - 01/2017
2	insulin receptor-related receptor (IRR)IBA 10/2021 - 01/2021
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 11/2018 - 02/2016
2	Mirtazapine (Rexer)FDA LinkGeneric 11/2018 - 02/2016
2	A-factor (Streptomyces)IBA 01/2017 - 01/2016
2	Biological ProductsIBA 09/2016 - 04/2016
2	Olanzapine (Zyprexa)FDA Link 09/2016 - 07/2002
2	Clozapine (Clozaril)FDA LinkGeneric 09/2016 - 07/2002
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2014 - 10/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021
1	CytokinesIBA 05/2021
1	Interleukin-12 (IL 12)IBA 05/2021
1	MicroRNAs (MicroRNA)IBA 05/2021
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	ORALIT (ORS)IBA 01/2021
1	CholesterolIBA 01/2021
1	Prazosin (Minipress)FDA LinkGeneric 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2018
1	Serotonin (5 Hydroxytryptamine)IBA 11/2018
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 11/2018
1	Risperidone (Risperdal Consta)FDA LinkGeneric 09/2016
1	Varenicline (Chantix)FDA Link 01/2016
1	5,6-dihydroxy-2-dimethylaminotetralin (M 7)IBA 09/2015
1	5,10-methylenetetrahydrofolic acidIBA 01/2007
1	Oxidoreductases (Dehydrogenase)IBA 01/2007
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2007
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2007
1	Vitamin K 2 (Vitamin K2)IBA 06/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 08/2015
2	Aftercare (After-Treatment) 01/2018 - 03/2014
1	Activities of Daily Living (ADL) 01/2020
1	Continuity of Patient Care 12/2019
1	Polypharmacy 01/2019
1	Drug Therapy (Chemotherapy) 07/2017
1	Length of Stay 09/2015